1194MO Canakinumab (CAN) + docetaxel (DTX) for the second- or third-line (2/3L) treatment of advanced non-small cell lung cancer (NSCLC): CANOPY-2 phase III results
Paz-Ares, L., Goto, Y., Lim, W.D.T., Halmos, B., Cho, B.C., Dols, M. Cobo, Gonzalez-Larriba, J.L., Zhou, C., Demedts, I., Atmaca, A., Baka, S., Mookerjee, B.P., Portella, S., Zhu, Z., Dharan, B., Reck, M.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Efficacy and safety of first-line durvalumab (D) ± tremelimumab (T) vs platinum-based chemotherapy (CT) based on clinical characteristics in patients with metastatic (m) NSCLC: Results from MYSTIC
Cho, B.C., Reinmuth, N., Lee, K.H., Ahn, M.-J., Luft, A., Van den Heuvel, M., Dols, M. Cobo, Smolin, A., Vicente, D., Moiseyenko, V., Antonia, S.J., Moulec, S. Le, Robinet, G., Natale, R., Garon, E.B., Nakagawa, K., Liu, F., Thiyagarajah, P., Peters, S., Rizvi, N.A.
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
First evidence of oncologic neuropathic pain prevalence after screening 8615 cancer patients. Results of the On study
García de Paredes, M.L., del Moral González, F., Martínez del Prado, P., Martí Ciriquián, J.L., Enrech Francés, S., Cobo Dols, M., Esteban González, E., Ortega Granados, A.L., Majem Tarruella, M., Cumplido Burón, J.D., Gascó Hernández, A., López Miranda, E., Ciria Santos, J.P., de Castro Carpeño, F.J.
Published in Annals of oncology (01.04.2011)
Published in Annals of oncology (01.04.2011)
Get full text
Journal Article
Emerging noninvasive methylation biomarkers of cancer prognosis and drug response prediction
Oliver, Javier, Garcia-Aranda, Marilina, Chaves, Patricia, Alba, Emilio, Cobo-Dols, Manuel, Onieva, Juan Luis, Barragan, Isabel
Published in Seminars in cancer biology (01.08.2022)
Published in Seminars in cancer biology (01.08.2022)
Get full text
Journal Article
1418P Impact of TTFields therapy on global and functional health-related quality of life (HRQoL) in metastatic non-small cell lung cancer (mNSCLC) from the pivotal LUNAR study
Kotecha, R., Leal, T.A., Raumlau, R., Zhang, L., Milanowski, J., Cobo Dols, M., Roubec, J., Petruzelka, L.B., Havel, L., Kalmadi, S., Ward, J.P., Andric, Z.G., Berghmans, T., Kloecker, G., Panikkar, R., Aerts, J.G., Pless, M., Greil, R., Akerley, W., Langer, C.J.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1481P Singular immune-related adverse events and efficacy outcomes of immune checkpoint inhibitors in advanced non-small cell lung cancer
Jurado García, J.M., Cobo Dols, M., Cantero, A., Gutierrez Calderon, V., Jiménez Gallego, P., Perez Ruiz, E., Berciano Guerrero, M.A., Montesa Pino, A., Ramos Garcia, I., Rueda Dominguez, A.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
9135 Erlotinib as maintenance therapy after platinun-based chemotherapy in advanced non-small-cell lung cancer (NSCLC): a phase II trial
Cobo-Dols, M, Barneto-Aranda, I, Bernabé-Caro, R, Valdivia, J, Fernandez-Canton, I, Cruzdela, L, Rueda-Ramos, A, Villatoro, R, Beló, J
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article
Survival outcomes in stage IV small-cell lung cancer (IV-SCLC): Analysis from SEER database
de Castro Carpeño, J., Dols, M. Cobo, Gomez, M. Domine, Gracia, P. Ruiz, Crama, L., Campelo, M.R. Garcia
Published in Annals of oncology (01.12.2019)
Published in Annals of oncology (01.12.2019)
Get full text
Journal Article
1064P Genomic characterization of first line advanced or metastatic non-small cell lung cancer (aNSCLC) patients (pts) subgroups associated with good/bad prognosis
Provencio Pulla, M., Perez Parente, D., Campos Balea, B., Rodriguez Abreu, D., Hasan, H., Olson, S., Pal, N., Wilkinson, S., De Oro Pulido, F., Ruiz Gracia, P., Cobo Dols, M.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
374TiP LAURA: Osimertinib maintenance following definitive chemoradiation therapy (CRT) in patients (pts) with unresectable stage III epidermal growth factor receptor mutation positive (EGFRm) non-small cell lung cancer (NSCLC)
Lu, S., Casarini, I., Kato, T., Dols, M. Cobo, Özgüroğlu, M., Zeng, L., van der Gronde, T., Saggese, M., Ramalingam, S.
Published in Annals of oncology (01.11.2020)
Published in Annals of oncology (01.11.2020)
Get full text
Journal Article
509MO Datopotamab deruxtecan (Dato-DXd) vs docetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): Results of the randomized phase III study TROPION-Lung01
Ahn, M-J., Lisberg, A.E., Paz-Ares, L., Cornelissen, R., Girard, N., Pons-Tostivint, E., Vicente Baz, D., Sugawara, S., Cobo Dols, M., Pérol, M., Mascaux, C., Poddubskaya, E., Kitazono, S., Hayashi, H., Sands, J., Hall, R., Zhang, Y., Zebger-Gong, H., Uema, D., Okamoto, I.
Published in Annals of oncology (01.11.2023)
Published in Annals of oncology (01.11.2023)
Get full text
Journal Article
1312MO Combining the antigen-presenting cell activator eftilagimod alpha (soluble LAG-3) and pembrolizumab: Overall survival data from the first line non-small cell lung carcinoma (NSCLC) cohort of TACTI-002 (phase II)
Carcereny, E., Felip, E., Majem, M., Doger de Spéville, B., Clay, T.D., Bondarenko, I., Peguero, J., Cobo Dols, M., Forster, M.D., Ursol, G., Kalinka, E., Garcia Ledo, G.M., Vila Martinez, L., Iams, W., Krebs, M.G., Kefas, J., Efthymiadis, K., Perera, S., Mueller, C., Triebel, F.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
2204P Clinical predictors and inflammatory markers for malignant pleural mesothelioma prognosis: A retrospective study in a Spanish Medical Oncology Unit
Guardamagna, M., Gonzalez, B. Villaescusa, Dolores, M.R. María, Gonzalez, E. Zamorano, Garcia, I. Ramos, Ruiz, A. Mesas, Perez, J.M. Trigo, Cantero, A., Calderon, V. Gutierrez, García, J.M. Jurado, Dominguez, A. Rueda, Mongil, R., Arrabal, R., Conejo, E. Alba, Dols, M. Cobo, Montanez, J.C. Benitez
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1995P Long-term benefit of atezolizumab plus chemotherapy in extensive stage small cell lung cancer (ES-SCLC): Exploratory analysis from the IMfirst study
García-Campelo, M.R., Dómine, M., de Castro Carpeño, J., Moreno Vega, A.L., Aix, S. Ponce, Arriola, E., Carcereny, E., Majem, M., Vence, G. Huidobro, Gonzalez, E. Esteban, Pradera, J. Fuentes, Ortega Granados, A.L.O., Morales, M. Guillot, Sureda, B. Massuti, Barragan, P. Lianes, Calderon, R. Alonso, Fajardo, C.A., Crama, L., Laborda, N. Lerones, Dols, M. Cobo
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1476P Outcomes to first-line pembrolizumab in patients with advanced NSCLC and high PD-L1 expression: A Spanish multicentric study
Piedra, A., Martinez Recio, S., Hernandez Gonzalez, A., Moran Bueno, M.T., Arriola, E., Recuero-Borau, J., Cobo Dols, M., Cordeiro González, P., Mosquera Martinez, J., García-Campelo, M.R., Calles Blanco, A., Alvarez, R.M., Zapata García, M., Isla Casado, M.D., Callejo Perez, A., Iranzo Gomez, P., Barba Joaquín, A., Sullivan, I.G., Felip, E., Majem, M.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1325P Sunvozertinib as first-line treatment in NSCLC patients with EGFR Exon20 insertion mutations
Yang, J.C-H., Wang, M., Chiu, C-H., Hsu, P-C., Mitchell, P., Chang, C.L., Kim, T.M., John, T., Greillier, L., Bazhenova, L., Carcereny, E., Spira, A.I., Shim, B., Lee, K.H., Cobo Dols, M., Ghiringhelli, F., Yip, C.W., Xiong, J., Jänne, P.A., Zhou, C.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
LBA12 Datopotamab deruxtecan (Dato-DXd) vs docetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): Results of the randomized phase III study TROPION-Lung01
Ahn, M-J., Lisberg, A., Paz-Ares, L., Cornelissen, R., Girard, N., Pons-Tostivint, E., Vicente Baz, D., Sugawara, S., Cobo Dols, M., Pérol, M., Mascaux, C., Poddubskaya, E., Kitazono, S., Hayashi, H., Sands, J., Hall, R., Zhang, Y., Zebger-Gong, H., Uema, D., Okamoto, I.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1278P ORIGEN: Multicenter study on the prevalence of EGFR gene mutations in patients with early-stage resectable non-small cell lung cancer in Spain
Nadal, E., Fernandez, C. Alvarez, Arasanz, H., Muñoz, S. Peralta, Quintela, M. Lázaro, Teixido, C., Calvo de Juan, V., Alvarez, R.M., Espinar, J. Baena, Valdivia-Bautista, J., Arriola, E., Lastra, R., Caro, R. Bernabe, Camacho, C., Cordellat, A. Blasco, Sureda, B. Massuti, Guillaumes, M. Campayo, Dols, M. Cobo, Manrique, T. Garcia, Marquez, G.J.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1384P Prognostic factors for survival in patients with metastatic lung adenocarcinoma: Analysis of the SEER database
Balea, B. Campos, de Castro Carpeño, J., Massuti, B., Vicente-Baz, D., Parente, D. Pérez, Gracia, P. Ruiz, Dols, M. Cobo
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
1281O Atezolizumab (atezo) vs platinum-based chemo in blood-based tumour mutational burden-positive (bTMB+) patients (pts) with first-line (1L) advanced/metastatic (m)NSCLC: Results of the Blood First Assay Screening Trial (BFAST) phase III cohort C
Dziadziuszko, R., Peters, S., Gadgeel, S.M., Mathisen, M.S., Shagan, S.M., Felip, E., Morabito, A., Cheema, P., Dols, M. Cobo, Andric, Z., Barrios, C.H., Yamaguchi, M., Dansin, E., Danchaivijitr, P., Johnson, M., Novello, S., Gandara, D.R., Schleifman, E., Wang, J., Mok, T.S.K.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article